Publicacions en què col·labora amb Mª Luz Martínez Chantar (4)

2021

  1. Dual Targeting of G9a and DNA Methyltransferase-1 for the Treatment of Experimental Cholangiocarcinoma

    Hepatology, Vol. 73, Núm. 6, pp. 2380-2396

2020

  1. Dual pharmacological targeting of hdacs and pde5 inhibits liver disease progression in a mouse model of biliary inflammation and fibrosis

    Cancers, Vol. 12, Núm. 12, pp. 1-27

2009

  1. Salermide, a Sirtuin inhibitor with a strong cancer-specific proapoptotic effect

    Oncogene, Vol. 28, Núm. 6, pp. 781-791

  2. Salermide, a Sirtuin inhibitor with a strong cancer-specific proapoptotic effect (Oncogene (2009) 28, (781-791) DOI: 10.1038/onc.2008.436)

    Oncogene